Concepedia

Satoshi Ebata

SE

Statistics

Publications

17

Citations

874

H-Index

15

Active since

2015

Affiliations

The University of Tokyo(Current)

University of Tokyo Hospital

National Center for Global Health and Medicine

Meisei University

National Institute of Advanced Industrial Science and Technology

Satoshi Ebata is an author at The University of Tokyo specializing in immunology, systemic sclerosis, and autoimmunity.

Publications per year

2015–2023

17

Publications

17

Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial

Satoshi Ebata, Ayumi Yoshizaki, Koji Oba et al. · The Lancet Rheumatology · 2021 · 259 citations

Medicine, Immunology, Pharmacotherapy +8

Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis

Ai Kuzumi, Ayumi Yoshizaki, Kazuki Matsuda et al. · Nature Communications · 2021 · 81 citations · Full text

Medicine, Immunology, Pathology +17

Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis

Takemichi Fukasawa, Ayumi Yoshizaki, Satoshi Ebata et al. · Arthritis & Rheumatology · 2017 · 78 citations · Full text

Life Sciences, Immunology, Pathology +17

Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial

Satoshi Ebata, Ayumi Yoshizaki, Koji Oba et al. · The Lancet Rheumatology · 2022 · 75 citations

Medicine, Immunology, Pharmacotherapy +10

Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti‐topoisomerase I‐positive systemic sclerosis‐associated interstitial lung disease

Satoshi Ebata, Ayumi Yoshizaki, Takemichi Fukasawa et al. · The Journal of Dermatology · 2019 · 65 citations

Life Sciences, Immunology, Pharmacotherapy +13

1–5 of 17